Trial Profile
KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Dec 2021
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Immune globulin
- Indications Mucocutaneous lymph node syndrome
- Focus Therapeutic Use
- Acronyms KIDCARE
- 05 Apr 2021 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified April 2019).
- 01 Apr 2021 Status changed from recruiting to completed.
- 01 Apr 2019 Trial design and protocol details of this study published in the Contemporary Clinical Trials Journal.